Creative Medical Technology (CELZ) late Thursday filed a preliminary prospectus for securities offering.

The filing covers a best efforts public offering of about 3.0 million shares and warrants to purchase up to some 6.1 million shares at a combined assumed price of $1.97 per share and accompanying warrants. Investors can also buy pre-funded warrants in lieu.

The use of proceeds includes for clinical studies, working capital and general corporate purposes, it said.